Ready, pause, go: Regulation of RNA polymerase II pausing and release by cellular signaling pathways

Trends in Biochemical Sciences

Volumn 40, Issue 9, 2015, Pages 516-525

  Liu, Xiuli ^a,b   Kraus, W Lee ^a,b   Bai, Xiaoying ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; POSITIVE ELONGATION FACTOR B; RNA POLYMERASE II; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; DROSOPHILA; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE TARGETING; HEART VENTRICLE HYPERTROPHY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMEDIATE EARLY GENE; MAMMAL CELL; MLL GENE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; RNA SEQUENCE; RNA SYNTHESIS; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; RNA POLYMERASE II; SIGNAL TRANSDUCTION;

EID: 84940467344     PISSN: 09680004     EISSN: 13624326     Source Type: Journal    
DOI: 10.1016/j.tibs.2015.07.003     Document Type: Review

References (109)

1. Gariglio P., et al. Clustering of RNA polymerase B molecules in the 5' moiety of the adult beta-globin gene of hen erythrocytes. Nucleic Acids Res. 1981, 9:2589-2598.
2. Rougvie A.E., Lis J.T. The RNA polymerase II molecule at the 5' end of the uninduced hsp70 gene of D. melanogaster is transcriptionally engaged. Cell 1988, 54:795-804.
3. Rasmussen E.B., Lis J.T. In vivo transcriptional pausing and cap formation on three Drosophila heat shock genes. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:7923-7927.
4. Strobl L.J., Eick D. Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo. EMBO J. 1992, 11:3307-3314.
5. Plet A., et al. Elongation and premature termination of transcripts initiated from c-fos and c-myc promoters show dissimilar patterns. Oncogene 1995, 10:319-328.
6. Law A., et al. Direct cloning of DNA that interacts in vivo with a specific protein: application to RNA polymerase II and sites of pausing in Drosophila. Nucleic Acids Res. 1998, 26:919-924.
7. Guenther M.G., et al. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007, 130:77-88.
8. Muse G.W., et al. RNA polymerase is poised for activation across the genome. Nat. Genet. 2007, 39:1507-1511.
9. Zeitlinger J., et al. RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat. Genet. 2007, 39:1512-1516.
10. Rahl P.B., et al. c-Myc regulates transcriptional pause release. Cell 2010, 141:432-445.
11. Nechaev S., et al. Global analysis of short RNAs reveals widespread promoter-proximal stalling and arrest of Pol II in Drosophila. Science 2010, 327:335-338.
12. Churchman L.S., Weissman J.S. Nascent transcript sequencing visualizes transcription at nucleotide resolution. Nature 2011, 469:368-373.
13. Core L.J., et al. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 2008, 322:1845-1848.
14. Kwak H., et al. Precise maps of RNA polymerase reveal how promoters direct initiation and pausing. Science 2013, 339:950-953.
15. Kruesi W.S., et al. Condensin controls recruitment of RNA polymerase II to achieve nematode X-chromosome dosage compensation. Elife 2013, 2:e00808.
16. Core L.J., et al. Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers. Nat. Genet. 2014, 46:1311-1320.
17. Lam M.T., et al. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 2013, 498:511-515.
18. Hah N., et al. A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 2011, 145:622-634.
19. Min I.M., et al. Regulating RNA polymerase pausing and transcription elongation in embryonic stem cells. Genes Dev. 2011, 25:742-754.
20. Core L.J., et al. Defining the status of RNA polymerase at promoters. Cell Rep. 2012, 2:1025-1035.
21. Danko C.G., et al. Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells. Mol. Cell 2013, 50:212-222.
22. Luo X., et al. Dynamic reorganization of the AC16 cardiomyocyte transcriptome in response to TNFalpha signaling revealed by integrated genomic analyses. BMC Genomics 2014, 15:155.
23. Heidemann M., et al. Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription. Biochim. Biophys. Acta 2013, 1829:55-62.
24. Hartzog G.A., Fu J. The Spt4-Spt5 complex: a multi-faceted regulator of transcription elongation. Biochim. Biophys. Acta 2013, 1829:105-115.
25. Yamaguchi Y., et al. Transcription elongation factors DSIF and NELF: promoter-proximal pausing and beyond. Biochim. Biophys. Acta 2013, 1829:98-104.
26. Cheng B., et al. Functional association of Gdown1 with RNA polymerase II poised on human genes. Mol. Cell 2012, 45:38-50.
27. Bunch H., et al. TRIM28 regulates RNA polymerase II promoter-proximal pausing and pause release. Nat. Struct. Mol. Biol. 2014, 21:876-883.
28. Buckley M.S., et al. Kinetics of promoter Pol II on Hsp70 reveal stable pausing and key insights into its regulation. Genes Dev. 2014, 28:14-19.
29. Chen F., et al. Stably paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor triptolide. Genes Dev. 2015, 29:39-47.
30. Henriques T., et al. Stable pausing by RNA polymerase II provides an opportunity to target and integrate regulatory signals. Mol. Cell 2013, 52:517-528.
31. Boettiger A.N., Levine M. Synchronous and stochastic patterns of gene activation in the Drosophila embryo. Science 2009, 325:471-473.
32. Lagha M., et al. Paused Pol II coordinates tissue morphogenesis in the Drosophila embryo. Cell 2013, 153:976-987.
33. Aiyar S.E., et al. Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. Genes Dev. 2004, 18:2134-2146.
34. Luecke H.F., Yamamoto K.R. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev. 2005, 19:1116-1127.
35. Amir-Zilberstein L., et al. Differential regulation of NF-kappaB by elongation factors is determined by core promoter type. Mol. Cell. Biol 2007, 27:5246-5259.
36. Chen K., et al. A global change in RNA polymerase II pausing during the Drosophila midblastula transition. Elife 2013, 2:e00861.
37. Gaertner B., et al. Poised RNA polymerase II changes over developmental time and prepares genes for future expression. Cell Rep. 2012, 2:1670-1683.
38. Hendrix D.A., et al. Promoter elements associated with RNA Pol II stalling in the Drosophila embryo. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7762-7767.
39. Fuda N.J., et al. GAGA factor maintains nucleosome-free regions and has a role in RNA polymerase II recruitment to promoters. PLoS Genet. 2015, 11:e1005108.
40. Li J., Gilmour D.S. Distinct mechanisms of transcriptional pausing orchestrated by GAGA factor and M1BP, a novel transcription factor. EMBO J. 2013, 32:1829-1841.
41. Marshall N.F., Price D.H. Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 1992, 12:2078-2090.
42. Marshall N.F., Price D.H. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 1995, 270:12335-12338.
43. Zhu Y., et al. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 1997, 11:2622-2632.
44. Peng J., et al. Identification of a cyclin subunit required for the function of Drosophila P-TEFb. J. Biol. Chem. 1998, 273:13855-13860.
45. Peng J., et al. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 1998, 12:755-762.
46. Marshall N.F., et al. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 1996, 271:27176-27183.
47. Fujinaga K., et al. Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Mol. Cell. Biol. 2004, 24:787-795.
48. Wada T., et al. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 1998, 12:343-356.
49. Yamada T., et al. P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation. Mol. Cell 2006, 21:227-237.
50. Jonkers I., et al. Genome-wide dynamics of Pol II elongation and its interplay with promoter proximal pausing, chromatin, and exons. Elife 2014, 3:e02407.
51. Conaway R.C., Conaway J.W. The Mediator complex and transcription elongation. Biochim. Biophys. Acta 2013, 1829:69-75.
52. Donner A.J., et al. CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat. Struct. Mol. Biol. 2010, 17:194-201.
53. Galbraith M.D., et al. HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. Cell 2013, 153:1327-1339.
54. Wu S.Y., Chiang C.M. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem. 2007, 282:13141-13145.
55. Diribarne G., Bensaude O. 7SK RNA, a non-coding RNA regulating P-TEFb, a general transcription factor. RNA Biol. 2009, 6:122-128.
56. Peterlin B.M., Price D.H. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 2006, 23:297-305.
57. Lis J. Promoter-associated pausing in promoter architecture and postinitiation transcriptional regulation. Cold Spring Harb. Symp. Quant. Biol. 1998, 63:347-356.
58. Lis J.T., et al. P-TEFb kinase recruitment and function at heat shock loci. Genes Dev. 2000, 14:792-803.
59. Saha R.N., et al. Rapid activity-induced transcription of Arc and other IEGs relies on poised RNA polymerase II. Nat. Neurosci. 2011, 14:848-856.
60. Zippo A., et al. Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 2009, 138:1122-1136.
61. Barboric M., et al. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 2001, 8:327-337.
62. Adelman K., et al. Immediate mediators of the inflammatory response are poised for gene activation through RNA polymerase II stalling. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:18207-18212.
63. Escoubet-Lozach L., et al. Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. PLoS Genet. 2011, 7:e1002401.
64. Gupte R., et al. Glucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:14616-14621.
65. Flajollet S., et al. The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors. PLoS ONE 2013, 8:e64880.
66. Lee D.K., et al. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation. J. Biol. Chem. 2001, 276:9978-9984.
67. Mitra P., et al. Estrogen receptor-alpha recruits P-TEFb to overcome transcriptional pausing in intron 1 of the MYB gene. Nucleic Acids Res. 2012, 40:5988-6000.
68. Kininis M., et al. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol. Cell. Biol. 2007, 27:5090-5104.
69. Kininis M., et al. Postrecruitment regulation of RNA polymerase II directs rapid signaling responses at the promoters of estrogen target genes. Mol. Cell. Biol. 2009, 29:1123-1133.
70. Gilchrist D.A., et al. Regulating the regulators: the pervasive effects of Pol II pausing on stimulus-responsive gene networks. Genes Dev. 2012, 26:933-944.
71. Lin C., et al. Dynamic transcriptional events in embryonic stem cells mediated by the super elongation complex (SEC). Genes Dev. 2011, 25:1486-1498.
72. Guo S., et al. A regulator of transcriptional elongation controls vertebrate neuronal development. Nature 2000, 408:366-369.
73. Jennings B.H., et al. Locus-specific requirements for Spt5 in transcriptional activation and repression in Drosophila. Curr. Biol. 2004, 14:1680-1684.
74. Amleh A., et al. Mouse cofactor of BRCA1 (Cobra1) is required for early embryogenesis. PLoS ONE 2009, 4:e5034.
75. Saunders A., et al. Extensive polymerase pausing during Drosophila axis patterning enables high-level and pliable transcription. Genes Dev. 2013, 27:1146-1158.
76. Bai X., et al. TIF1gamma controls erythroid cell fate by regulating transcription elongation. Cell 2010, 142:133-143.
77. Bottardi S., et al. Direct protein interactions are responsible for Ikaros-GATA and Ikaros-Cdk9 cooperativeness in hematopoietic cells. Mol. Cell. Biol. 2013, 33:3064-3076.
78. Bottardi S., et al. Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription elongation. Nucleic Acids Res. 2011, 39:3505-3519.
79. Elagib K.E., et al. Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation. Blood 2008, 112:4884-4894.
80. Elagib K.E., et al. Calpain 2 activation of P-TEFb drives megakaryocyte morphogenesis and is disrupted by leukemogenic GATA1 mutation. Dev. Cell 2013, 27:607-620.
81. Meier N., et al. Novel binding partners of Ldb1 are required for haematopoietic development. Development 2006, 133:4913-4923.
82. Song S.H., et al. Multiple functions of Ldb1 required for beta-globin activation during erythroid differentiation. Blood 2010, 116:2356-2364.
83. Williams L.H., et al. Pausing of RNA polymerase II regulates mammalian developmental potential through control of signaling networks. Mol. Cell 2015, 58:311-322.
84. Lin C., et al. The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation. Cell 2013, 152:144-156.
85. Liu L., et al. Transcriptional pause release is a rate-limiting step for somatic cell reprogramming. Cell Stem Cell 2014, 15:574-588.
86. Krystof V., et al. Perspective of cyclin-dependent kinase 9 (CDK9) as a drug target. Curr. Pharm. Des. 2012, 18:2883-2890.
87. Lin C.Y., et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012, 151:56-67.
88. Popovic R., Zeleznik-Le N.J. MLL: how complex does it get?. J. Cell. Biochem. 2005, 95:234-242.
89. Smith E., et al. The super elongation complex (SEC) and MLL in development and disease. Genes Dev. 2011, 25:661-672.
90. Dawson M.A., et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 2011, 478:529-533.
91. Yankulov K., Bentley D. Transcriptional control: Tat cofactors and transcriptional elongation. Curr. Biol. 1998, 8:R447-R449.
92. Gu J., et al. Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4. Cell Cycle 2014, 13:1788-1797.
93. He N., et al. HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol. Cell 2010, 38:428-438.
94. Sobhian B., et al. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol. Cell 2010, 38:439-451.
95. Tahirov T.H., et al. Crystal structure of HIV-1 Tat complexed with human P-TEFb. Nature 2010, 465:747-751.
96. Schulze-Gahmen U., et al. AFF4 binding to Tat-P-TEFb indirectly stimulates TAR recognition of super elongation complexes at the HIV promoter. Elife 2014, 3:e02375.
97. Kulkarni P.A., et al. Phosphorylation of RNA polymerase II in cardiac hypertrophy: cell enlargement signals converge on cyclin T/Cdk9. Recent Prog. Horm. Res. 2004, 59:125-139.
98. Sano M., et al. Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nat. Med. 2002, 8:1310-1317.
99. Huang F., et al. Ablation of the CLP-1 gene leads to down-regulation of the HAND1 gene and abnormality of the left ventricle of the heart and fetal death. Mech. Dev. 2004, 121:559-572.
100. Sunagawa Y., et al. Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes. J. Biol. Chem. 2010, 285:9556-9568.
101. Gutierrez S.H., et al. Cardiac role of the transcription factor NF-kappaB. Cardiovasc. Hematol. Disord. Drug Targets 2008, 8:153-160.
102. Anand P., et al. BET bromodomains mediate transcriptional pause release in heart failure. Cell 2013, 154:569-582.
103. Lam M.T., et al. Enhancer RNAs and regulated transcriptional programs. Trends Biochem. Sci. 2014, 39:170-182.
104. Hah N., et al. Enhancer transcripts mark active estrogen receptor binding sites. Genome Res. 2013, 23:1210-1223.
105. Kaikkonen M.U., et al. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol. Cell 2013, 51:310-325.
106. Wang D., et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011, 474:390-394.
107. Louie M.C., et al. Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2226-2230.
108. Ghavi-Helm Y., et al. Enhancer loops appear stable during development and are associated with paused polymerase. Nature 2014, 512:96-100.
109. Schaukowitch K., et al. Enhancer RNA facilitates NELF release from immediate early genes. Mol. Cell 2014, 56:29-42.